KeypointsCandidiasis was found in a number of laryngeal biopsy specimens tested. These patients had no reported visual evidence of candidiasis on laryngoscopy.Laryngeal candidiasis was more commonly identified in the pathology samples of those with documented use of inhaled corticosteroid therapy (20%) than those without documented use (10%).Local discussion between otolaryngologists and pathologists on the testing of laryngeal samples for candidiasis is required to ensure appropriate investigations are performed in a standardised manner.INTRODUCTIONPersistent throat symptoms, such as dysphonia, globus and throat pain, are highly prevalent and are a significant cause of morbidity. In a number of cases, a clear cause of these symptoms is not identified, and many patients are treated empirically with lifestyle advice and/or anti‐reflux medication.There is an increasing frequency of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), with associated increased use of inhaled corticosteroids (ICS). Oropharyngeal candidiasis is a well‐recognised complication of ICS, particularly when inhaler technique and oropharyngeal hygiene are poor. There is, however, limited evidence on the prevalence of laryngeal candidiasis in those taking ICS. While clinical diagnosis is sometimes possible, it has been highlighted in oropharyngeal candidiasis that clinical findings do not always correlate with the presence of fungi.We hypothesised
Clinical Otolaryngology – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera